| Continued from Page
2
The future
Transcervical
sterilization vs.
tubal ligation |
|
Advantages
> Local anesthesia used
> Potentially safer
> No incision necessary
> Performed in office
> Potentially less discomfort
> Quicker recovery
(one to two days vs. one week)
> High effectiveness rate
> Available to some women for which tubal
ligation is contraindicated
Disadvantages
> Not immediately effective (takes at least
three months)
> Special equipment and additional training
required to perform
> Long-term health effects unknown
> Abnormal fallopian tubes and/or uterine
cavities a contraindication
> Uncertainty regarding insurance coverage
for procedure
> Difficult to impossible to reverse
SOURCES: Conceptus
Inc. [www.essure.com];
Questions And Answers About Transcervical
Sterilization. Association of Reproductive
Health Professionals
|
While the Essure method is the only
FDA-approved transcervical sterilization procedure
now available
for patient use, several other sterilization
methods are in various stages of development.
> Adiana Inc., has developed a technology
for permanent transcervical contraception
using electrothermal energy.14 The system,
which now
is in clinical trials, uses a catheter to
deliver 60 seconds of temperature-controlled
radiofrequency
energy to the fallopian tube. Then a porous
implant is placed into the lesion left by the
electrothermal
energy. Over a few weeks, tissue grows into
the implant and occludes the tubes. Adiana
reported
that of the first 100 women who had undergone
the procedure in the EASE (evaluation of
the Adiana system for sterilization) trial,
the tubal
implants were successfully placed on the
first attempt. No pregnancies have been reported
to
date.14
> The use of two antibiotics, quinacrine
and erythromycin, as sterilization drugs
is also in pretrial status. The method for
using each
of the drugs is similar, in that the drug
in pellet form is placed in the fallopian
tubes
to cause scarring and eventual occlusion
of the tubes.1
> The intratubal ligation device, which is also
in pretrial status, uses the transcervical
method to place a ring over the fallopian tubes to create
a mechanical blockage.1
> In addition, several transcervical methods of
female sterilization are under investigation
in Europe, including Ovabloc, P-block, the
Hamou tubal plug, the Microsulis tubal occlusion method,
and an intrauterine balloon.1 The intrauterine
balloon works by inserting a tissue adhesive
into the fallopian tubes.1
Transcervical sterilization could very well
replace traditional tubal ligation as the most
common sterilization method in the future.
The FDA’s approval of the Essure procedure
is an important first step in the move toward
a safe, effective, and economical method of transcervical
sterilization.
On the horizon are even more options for women
seeking a minimally invasive method of permanent
contraception.
Kimberly A. Johnston, RN, EdD, is chairperson
of the Department of Nursing at Kutztown University,
Kutztown, Pa.
References
1. Farrington
A. Permanent Contraception for Women in the United
States. Association of Reproductive Health Professionals
Website. Available at: www.arhp.org/healthcareproviders/onlinepublications/healthandsexuality/
permanentoptions/
PermanentOptionfor WomenintheUS.cfm. Accessed
January 8, 2004.
2. Study demonstrates improvements with new
coil catheter for Essure. Women’s Health
Weekly. August 14, 2003:29-30.
3. Hatcher RA, Nelson AL, Zieman M, Darney PD,
Creinin MD, Stosur HR. A Pocket Guide to Managing
Contraception. 4th ed. Tiger, GA: Bridging the
Gap Foundation; 2001.
4. Kolander CA, Ballard DJ, Chandler CK. Contemporary
Women’s Health: Issues for Today and the
Future. Boston, MA: McGraw-Hill Publishing; 1999.
5. The Boston Women’s Health Book Collective.
Our Bodies, Ourselves. For the New Century. New
York: Simon & Schuster; 1998.
6. Planned Parenthood Federation of America
Inc. FDA approves innovative non-incision permanent
birth control procedure for women. Available
at: www.plannedparenthood.org/ about/pr/021105_birthcontrol.html.
Accessed January 8, 2004.
7. Key milestone reached with Blue Cross/Blue
Shield coverage of the Essure. Women’s
Health Weekly. July 24, 2003:29-30.
8. Scalpel-free permanent contraception slashes
recovery time. Health. 2003;17(1):105.
9. Cooper JM, Carignan CS, Cher D, Kerin JF.
Microinsert nonincisional hysteroscopic sterilization.
Obstet Gynecol. 2003;102(1):59-67.
10. Essure [patient information booklet]. San
Carlos, CA: Conceptus Inc.; 2003:10.
11. Rosen DMB. ANZJOG. 2004;44:62-64.
12. Minkin MJ, Hanlon T. New: Permanent birth
control. Prevention. 2003;55(9):109.
13. Essure Permanent Birth Control: Clinical
Testing. Available at: www.essure.com/consumer/c_clinical_testing.aspx.
Conceptus, Inc., Website. Accessed January 8,
2004.
14. Adiana Inc. Reports Treatment of First 100
Women in EASE Transcervical Sterilization Trial.
July 17, 2003. PR Newswire Association, Inc.,
Website. Available at: www.findarticles.com/
cf_dls/m4PRN/2003_July_17/105511185/p1/
article.jhtml. Accessed February 24, 2004.
|